Compounds > 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
Page last updated: 2024-08-26

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Reticulum Cell-Like Sarcoma, Yoshida

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Reticulum Cell-Like Sarcoma, Yoshida in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bär, V; Eckhardt, S; Erdélyi, V; Foris, G; Pollák, Z1

Other Studies

1 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Reticulum Cell-Like Sarcoma, Yoshida

ArticleYear
[Investigation on radiosensitizing and tumor inhibiting actions of the antioxidant MTDQ (6,6'-methylen-bis/2,2,4-trimethyl-1-1,2-dihydroquinolin) (author's transl)].
    Archiv fur Geschwulstforschung, 1975, Volume: 45, Issue:5

    Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Ehrlich Tumor; Female; Male; Mice; Neoplasm Transplantation; Quinolines; Radiation-Sensitizing Agents; Sarcoma, Yoshida

1975